Director and part-time General Counsel Christos Nicholoudis resigns

MIRA PHARMACEUTICALS, INC.

Christos Nicholoudis resigned from the Board and as part-time General Counsel effective January 15, 2024.
Resignation did not involve disagreements with the Company, management, or Board.
No replacement for the director or General Counsel role announced in the filing.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Christos Nicholoudis

Director and part-time General Counsel

MIRA · MIRA PHARMACEUTICALS, INC.

Effective: 2024-01-15
Filed: January 17, 2024, 6:59 PM ET

On January 15, 2024, Christos Nicholoudis, Esq. resigned from the Board of Directors of the Company and as part-time General Counsel of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Christos Nicholoudis resigned as Director and part-time General Counsel at MIRA PHARMACEUTICALS, INC..

Action: resigned
Role: Director and part-time General Counsel

Exact text from the filing

On January 15, 2024, Christos Nicholoudis, Esq. resigned from the Board of Directors of the Company and as part-time General Counsel of the Company.

View on SEC.gov

MIRA PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001493152-24-002729

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.